Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-22-168473
Filing Date
2022-06-06
Accepted
2022-06-06 17:17:06
Documents
3
Group Members
CARLYLE HOLDINGS II GP L.L.C.CARLYLE HOLDINGS II L.L.C.CARLYLE PARTNERS VI CAYMAN HOLDINGS, L.P.CG SUBSIDIARY HOLDINGS L.L.C.TC GROUP CAYMAN INVESTMENT HOLDINGS SUB L.P.TC GROUP CAYMAN INVESTMENT HOLDINGS, L.P.TC GROUP VI CAYMAN, L.L.C.TC GROUP VI CAYMAN,

Document Format Files

Seq Description Document Type Size
1 SC 13D d339864dsc13d.htm SC 13D 195199
2 EX-99.1 d339864dex991.htm EX-99.1 13098
3 EX-99.3 d339864dex993.htm EX-99.3 11658
  Complete submission text file 0001193125-22-168473.txt   222135
Mailing Address C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Business Address C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004 202 729 5626
Carlyle Group Inc. (Filed by) CIK: 0001527166 (see all company filings)

EIN.: 452832612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Subject) CIK: 0001906324 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93684 | Film No.: 22998910
SIC: 2835 In Vitro & In Vivo Diagnostic Substances